Who owns UNITY BIOTECHNOLOGY, INC.?
- Ticker: UBX
- CUSIP Number: 91381u200
Tip: Access positions for across all investors
Analyze quarterly positions in Unity Biotechnology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Unity Biotechnology stock
Who bought or sold UNITY BIOTECHNOLOGY, INC. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Arch Venture Corp | 1.0M | $1.6M | 0% | Mar 2024 |
|
| Alyeska Investment Group | 920k | $1.5M | -60% | Mar 2024 |
|
| Vanguard Group | 557k | $914k | -1% | Mar 2024 |
|
| Geode Capital Management | 134k | $220k | 2% | Mar 2024 |
|
| Mayo Clinic | 124k | $204k | 0% | Mar 2024 |
|
| BlackRock | 112k | $184k | -1% | Mar 2024 |
|
| Citadel Advisors | 102k | $168k | 51% | Mar 2024 |
|
| UBS O'Connor | 70k | $116k | 100% | Mar 2024 |
|
| Bridgeway Capital Management | 50k | $82k | 0% | Mar 2024 |
|
| Founders Fund V Management | 49k | $81M | 0% | Mar 2024 |
|
| Wells Fargo & Company | 44k | $71k | 0% | Mar 2024 |
|
| Cercano Management | 41k | $68k | 0% | Mar 2024 |
|
| Millennium Management | 38k | $62k | 181% | Mar 2024 |
|
| Morgan Stanley | 37k | $61k | 22% | Mar 2024 |
|
| Commonwealth Equity Services | 25k | $40k | 4% | Mar 2024 |
|
| Northern Trust | 23k | $37k | 4% | Mar 2024 |
|
| Captrust Financial Advisors | 18k | $29k | 100% | Mar 2024 |
|
| Susquehanna International | 16k | $27k | -75% | Mar 2024 |
|
| Squarepoint Ops | 14k | $23k | 100% | Mar 2024 |
|
| Endowment Wealth Management | 14k | $22k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 13k | $22k | -1% | Mar 2024 |
|
| CIBC Global Asset Management | 11k | $17k | 0% | Mar 2024 |
|
| LPL Financial | 11k | $17k | 100% | Mar 2024 |
|
| Steward Partners Investment Advisory | 6.3k | $10k | 100% | Mar 2024 |
|
| Tower Research Capital | 4.9k | $8.1k | 100% | Mar 2024 |
|
| UBS Group | 3.5k | $5.7k | -62% | Mar 2024 |
|
| Simplex Trading | 1.6k | $2.0k | -30% | Mar 2024 |
|
| Cape Investment Advisory | 300.00 | $579.000000 | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 271.00 | $444.006400 | 5% | Mar 2024 |
|
| Signature | 200.00 | $328.000000 | 0% | Mar 2024 |
|
| Royal Bank of Canada | 141.00 | $0 | -69% | Mar 2024 |
|
| Rhumbline Advisers | 129.00 | $211.005300 | 0% | Mar 2024 |
|
| Carmichael Hill & Associates | 100.00 | $164.000000 | 0% | Mar 2024 |
|
| Summit Investment Advisors | 100.00 | $164.000000 | 0% | Mar 2024 |
|
| AllSquare Wealth Management | 55.00 | $90.002000 | 0% | Mar 2024 |
|
| Qube Research & Technologies | 18.00 | $30.000600 | 0% | Mar 2024 |
|
| FMR | 10.00 | $16.000000 | -89% | Mar 2024 |
|
Who sold out of Unity Biotechnology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Dec 2023 | 29k | $55k |
| Dimensional Fund Advisors | Dec 2023 | 26k | $49k |
| Laurion Capital Management | Dec 2023 | 22k | $42k |
| Wolverine Trading | Dec 2023 | 11k | $20k |